¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥: Themicrobiomeinurologicaldiseases : 2022-02-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥: Themicrobiomeinurologicaldiseases : 2022-02-19
±³À°ÀÏÀÚ : 2022-02-19
±³À°Àå¼Ò : ¿©¼ö À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏġȦ  
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥: Themicrobiomeinurologicaldiseases
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ  
´ã´çÀÚ : ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ
¿¬¶ôó : 02-2038-7988  
À̸ÞÀÏ : gaonpco@gaonpco.com      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 4 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í È¸¿ø(¿¬È¸ºñ ³³ºÎ): ¹«·á ȸ¿ø(¿¬È¸ºñ ¹Ì³³): 10,000¿ø ºñȸ¿ø: 100,000¿ø Àü°øÀÇ ¹× °£È£»ç: ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 10:00~10:15 Dysbiosis & SCFA: Mechanisms and Functional Importance in the Gut.  ±èÈ«¿í(°Ç¾çÀÇ´ë) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 10:15~10:30 SCFA & Urological Disease (Dysbiosis in Urological Diseases : e.g BPS/IC, UUI/OAB, CP/CPPS, Stone, Prostate Cancer, Bladder Cancer)  ¾çÈñÁ¶(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 10:30~10:45 Polyphenol as Modulators of Gut Microbiota Dysbiosis (in the context of prostate health)  °íÇõÁØ(µ¿¾ÆÀÇ´ë) 
Åä·Ð 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 10:45~11:00 Panel Discussion  ¹Î½Â±â(°ñµå¸¸ºñ´¢ÀÇÇаú) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 11:00~11:20 Human genome project & next generation sequencing  À̱æÈ£(´Ü±¹ÀÇ´ë) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 11:20~11:40 Microbiome Diagnostics (16S ribosomal RNA, whole genome sequencing)  À̹̰æ(Áß¾ÓÀÇ´ë Áø´Ü°Ë»çÀÇÇаú) 
È޽Ġ02-19  11:40~11:50 Coffee Break  () 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 11:50~12:05 Male Bladder Microbiome Relates to Lower Urinary Tract Symptoms  Á¤½ÂÀÏ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 12:05~12:20 Impact of Covid-19 on LUTS in Patients with BPH  ÃÖÁß¿ø(Áß¾Óº¸Èƺ´¿ø) 
Åä·Ð 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 12:20~12:35 Panel Discussion  ¹ÚÈïÀç(¼º±Õ°üÀÇ´ë) 
½Ä»ç 02-19  12:35~13:20 Lunch  () 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 13:20~13:35 Biofilm and Quorum Sensing Inhibitors  ÃÖÇö¼·(°¡Å縯ÀÇ´ë) 
È޽Ġ02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 13:35~13:50 Bacteriophage-Derived Endolysins to Target Gram-Negative Bacteria.  À¯¼ºÇö(Àü³²ÀÇ´ë) 
Åä·Ð 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 13:50~14:05 Panel Discussion  ÀåÀÎÈ£(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 14:05~14:20 FMT for Recurrent Cystitis  ±è¿¬ÁÖ(´ë±¸ÆÄƼ¸¶º´¿ø) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 14:20~14:35 Effect of ICU Catheter Management by Urologists on the Occurrence and Prevention of CAUTI  ¹è»ó¶ô(°¡Å縯ÀÇ´ë) 
Åä·Ð 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 14:35~14:50 Panel Discussion  À̽ÂÁÖ(°¡Å縯ÀÇ´ë) 
È޽Ġ02-19  14:50~15:00 Coffee Break  () 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 15:00~15:15 Urinary tract infections in patients underwent radical cystectomy with urinary diversion  ÀÌÁÖ¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 15:15~15:30 Antibiotic Stewardship and Postoperative Infections in Urethroplasties  ¹Ú¹Î±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 15:30~15:45 Manangement of Fournier Gangrene (Reconstruction of Defects After Fournier Gangrene ; skin grafts vs flaps)  ÀÌÁ¤¿ì(°æÈñÀÇ´ë) 
Åä·Ð 02-19 À¯Å¾¸¶¸®³ªÈ£ÅÚ 2Ãþ ±×¸®´ÏÄ¡ Ȧ 15:45~16:10 Panel Discussion  ³ª¿õ(±¹¸³Áß¾ÓÀÇ·á¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥: Themicrobiomeinurologicaldiseases : 2022-02-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑÀÓ»ó¼øȯ±âÇÐȸ ¿Â¶óÀÎ Echo Festival 2022 : 2022-02-20
´ÙÀ½±Û ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ 2022 ½ÅÀÔ È£Èí±â ÀÓ»ó°­»ç ¿öÅ©¼ó : 2022-02-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 688 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 735 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 861 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 796 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 813 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,146 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,108 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,062 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 985 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,226 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,514 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,391 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,201 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,424 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,977 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷